Current role
Corporate Strategy
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Corporate Strategy
The proxy statement of Sangamo Therapeutics, Inc reports total compensation of $2,590,066 for Corporate Strategy in fiscal 2018, including a base salary of $120,390.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Sangamo Therapeutics, Inc (SGMOQ)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sangamo Therapeutics, Inc
Other people whose current roles at this company are on record from its filings.
- Alexander D. Macrae CEO, Board Member
- Kathy Y. Yi CFO
- Nikunj Jain CFO, Chief Accounting Officer
- Sung H. Lee CFO
- D. Mark McClung COO
- Scott B. Willoughby General Counsel
- Alexander D. Macrae, M.B., Ch.B., Ph.D. Board Member
- Courtney Beers Board Member
- Courtney Beers, Ph.D. Board Member
- Courtney Beers, PhD. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2018 | Sangamo Therapeutics, Inc (SGMOQ) | — | $120,390 | $2,590,066 |
Recent activity
No call appearances or filed executive changes recorded yet.